Guiding the Path to Commercialization Success
Guiding the Path to Commercialization Success
Steep Health helps early-stage MedTech and HealthTech companies overcome the commercialization barriers that prevent breakthrough innovations into real-world adoption, scalable growth, and measurable global healthcare impact.
Contact us today to schedule a consultation and discover how we can help take your business to the next level.
Steven Pusterla

Brilliant medical technologies fail every day, not because the science is weak, but because commercialization is complex. Early-stage MedTech companies must simultaneously solve clinical validation, regulatory alignment, reimbursement strategy, economic value, and enterprise health system adoption. This intersection of scientific innovation and commercial reality is often called the MedTech Valley of Death, where many promising companies stall before achieving scale.
We partner with early and growth-stage MedTech, HealthTech, AI, and data-driven healthcare companies to design and execute the strategies required for successful commercialization. Our focus is on solving the critical barriers that prevent adoption and scale, including economic value creation, reimbursement strategy, enterprise health system engagement, pricing and contracting architecture, and the development of scalable commercial infrastructure.

Led by Steven Pusterla, a healthcare commercialization executive with more than 25 years of experience building high-growth commercial organizations across MedTech, HealthTech, AI, and SaaS platforms, Steep Health brings the strategic insight and operational leadership required to transform innovation into measurable clinical and economic impact.

Help transformative healthcare technologies move from promising innovation to widespread clinical adoption and sustainable growth.
Commercial execution does.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.